Novartis Ag (NVS) Total Liabilities (2009 - 2026)

Novartis Ag has disclosed Total Liabilities across 18 years of filings, most recently posting $80.1 billion for Q2 2026.

• In Q2 2026, Total Liabilities rose 28.47% year-over-year to $80.1 billion; the TTM figure through Jun 2026 stood at $80.1 billion (up 28.47% YoY), while the FY2025 annual figure was $64.4 billion, up 10.81% from the prior year.
• Total Liabilities came in at $80.1 billion for Q2 2026 at Novartis Ag, up from $79.6 billion in the prior quarter.
• In the past five years, Total Liabilities ranged from a high of $80.1 billion in Q2 2026 to a low of $53.2 billion in Q4 2023.
• Average Total Liabilities over 5 years is $62.5 billion, with a median of $60.1 billion recorded in 2023.
• Year-over-year, Total Liabilities fell 19.3% in 2024 and rose 29.46% in 2026.
• Over 5 years, Total Liabilities stood at $58.0 billion in 2022, then slipped by 8.33% to $53.2 billion in 2023, then advanced by 9.26% to $58.1 billion in 2024, then rose by 10.81% to $64.4 billion in 2025, then gained by 24.36% to $80.1 billion in 2026.
• Per Business Quant data, the three most recent Total Liabilities figures were $80.1 billion in Q2 2026, $79.6 billion in Q1 2026, and $64.4 billion in Q4 2025.